AMRN

Amarin Corporation PLC News Headlines

$1.62
*  
0.01
 negative 
0.61%
Get AMRN Alerts
*Delayed - data as of Apr. 23, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Amarin Takes Step 1, Of A Million, To Right Its Ship
4/1/2014 3:21:00 PM - Seeking Alpha

Largest option trades in equities
4/1/2014 11:24:58 AM - optionMONSTER

Sector Update: Healthcare Shares Flat in Pre-Market Trade; Amarin Partners with Kowa to Promote Vascepa
4/1/2014 8:55:29 AM - MT Newswires

Sector Update: Healthcares
4/1/2014 8:54:41 AM - MT Newswires

Adherex At ASCO, FDA Panel Backs CBST, DRTX, PRAN's IMAGINE Fails, SKBI Shines
4/1/2014 1:08:00 AM - RTT News

Amarin: How The Co-Promotion Agreement With Kowa Affects Required Sales Targets
4/1/2014 12:53:00 AM - Seeking Alpha

Amarin In Co-Promotion Deal With Kowa For U.S. Sales Of Vascepa Capsules
3/31/2014 5:15:00 PM - RTT News

Looking For Value Among Biotechs After Precipitous Declines In Stock Price
3/24/2014 12:26:00 PM - Seeking Alpha

Amarin Q4 13 Earnings Conference Call At 4:30 PM ET
2/27/2014 3:00:00 PM - RTT News

Amarin Is Likely Now A Vortex Where Your Money Will Go To Die
2/26/2014 2:16:00 PM - Seeking Alpha

What Now For Amarin?
2/25/2014 2:54:00 PM - Seeking Alpha

Amarin's Vascepa Gets 3-Year Exclusivity - Analyst Blog
2/24/2014 6:20:01 PM - Zacks.com

FDA Awards Amarin 3-Yr Exclusivity For Vascepa Capsules
2/21/2014 4:12:00 PM - RTT News

Amarin Tumbles after DMEP Decision - Analyst Blog
1/22/2014 6:10:01 PM - Zacks.com

Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal - Analyst Blog
1/22/2014 2:01:01 PM - Zacks.com

FDA To Amarin: 'I Said Good Day, Sir!'
1/21/2014 10:10:00 AM - Seeking Alpha

Amarin: Is No News Good News?
1/20/2014 4:13:00 PM - Seeking Alpha

Pre-Market Most Active for Jan 16, 2014 : BBY, BAC, C, BHP, JCP, FOX, RESI, SRPT, FB, AMRN, MU, DRYS
1/16/2014 9:39:56 AM - NASDAQ.com News

Amarin Delay Piques Investor Interest And Sparks Debate
1/16/2014 4:12:00 AM - Seeking Alpha

After Hours Most Active for Jan 15, 2014 : C, JPM, WFC, F, BAC, MET, QQQ, MSFT, MU, SIRI, AMRN, SPIL
1/15/2014 5:43:18 PM - NASDAQ.com News

Stock Watch Monday, 13 January 2014: Intercept Soars As Focus Shifts To Healthcare Market Trends
1/13/2014 9:06:00 AM - Seeking Alpha

While Amarin Continues To Go Rancid, Neptune Will Soar
1/11/2014 8:34:00 AM - Seeking Alpha

Small Cap BioPharmas With Near-Term Catalysts
1/3/2014 7:55:00 AM - Seeking Alpha

Chelsea: FDA Panel Meeting And Trading Strategies
12/30/2013 4:34:00 PM - Seeking Alpha

Amarin: 3 Things Shareholders Should Demand In 2014
12/30/2013 12:13:00 AM - Seeking Alpha